Inefficacy of clarithromycin in advanced multiple myeloma: A definitive report [1]

Pellegrino Musto, Antonietta Falcone, Grazia Sanpaolo, Carlo Bodenizza, Mario Carotenuto, Angela Michele Corella

Research output: Contribution to journalArticlepeer-review

Abstract

Fifty-one patients with relapsed or resistant multiple myeloma received clarithromycin p.o. at the dose of 500 mg b.i.d Thirteen patients did not complete the planned therapeutic program of 12 weeks due to side effects or progression. Among the 38 evaluable patients, objective or minor responses occurred in one and two patients, respectively. Our data do not support the use of clarithromycin for the treatment of advanced multiple myeloma.

Original languageEnglish
Pages (from-to)658-659
Number of pages2
JournalHaematologica
Volume87
Issue number6
Publication statusPublished - 2002

Keywords

  • Clarithromycin
  • Myeloma

ASJC Scopus subject areas

  • Hematology

Fingerprint

Dive into the research topics of 'Inefficacy of clarithromycin in advanced multiple myeloma: A definitive report [1]'. Together they form a unique fingerprint.

Cite this